LONDON, UK—-29th April 2010—-New Publications. Today VacZine Analytics releases a new publication investigating the epidemiology and burden of the hospital pathogen Clostridium difficile in “Rest of World” and emerging markets. The publication continues the longstanding company interest in C.diff and takes a further step to understanding the impact of the pathogen globally.DiseaseINFOPACK: [...]
Archive of posts filed under the Uncategorized category.
VacZine Analytics releases MarketVIEW: Pseudomonas aeruginosa vaccines
LONDON, UK—-29th April 2010—-New Publications. Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for Pseudomonas aeruginosa vaccines MarketVIEW: Pseudomonas aeruginosa vaccines models the global market for a vaccine to prevent life-threatening infections from this problematic hospital pathogen. The product gives a comprehensive vaccine value [...]
VacZine Analytics: begins UK recruitment drive to meet increased demand
LONDON, UK—-9th February 2010—-Corporate News. VacZine Analytics begins recruitment drive at UK-offices to meet increased demand for products/services. Commenting on the situation: John Savopoulos, Group Director added, “In the past years the vaccine industry continues to witness incredible growth, now especially after the supply of vaccines for the H1N1 pandemic. At VacZine Analytics, we [...]
European Summer Congress on Vaccines and Immunization, Porto Heli, Greece (June 2010)
LONDON, UK—-9th February 2010—-Corporate News. VacZine Analytics is proud to be part of the organising committee for the European Summer Congress on Vaccines And Immunization, Porto Heli, Greece – June 23rd-25th. For more information: VISIT SITE.
Welcome!
Welcome to VacZineBLOG – a new service from VacZine Analytics.
VacZineBLOG is a discussion forum for monitoring new vaccines linked to our new Vaccine Pipeline Review database at: http://www.vaccinestats.com and ongoing ExpertREACT newletter at: http://www.vaczine-analytics.com/products-expertreact.asp